Effect of grapefruit juice on serum voriconazole concentrations in the mouse

Medical Mycology

Volumn 38, Issue 3, 2000, Pages 209-212

  Sugar, Alan M ^a   Liu, X P ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Antifungal therapy; Cytochrome P450; Grapefruit juice; Voriconazole

Indexed keywords

CYTOCHROME P450; VORICONAZOLE;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SCREENING; EXPERIMENTAL INFECTION; FOOD DRUG INTERACTION; FRUIT JUICE; GRAPE; MALE; MOUSE; MYCOSIS; NONHUMAN;

ANIMALIA; CAVIA PORCELLUS; CITRUS X PARADISI; SUS SCROFA; VITIS SP.;

EID: 0034042868     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.38.3.209.212     Document Type: Article

References (18)

1. Barry AL, Brown SD. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrob Agents Chemother 1996; 40: 1948-1949.
2. George D, Miniter P, Andriole VT. Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother 1996; 40: 86-91.
3. Ghannoum MA, Okogbule-Wonodi I, Bhat N, Sanati H. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. J Chemother 1999; 11: 34-39.
4. Marco F, Pfaller MA, Messer SA, Jones RN. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 1998; 36: 433-436.
5. Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 1998; 36: 1436-1438.
6. Hegener P, Troke PF, Fatkenheuer G, Diehl V, Ruhnke M. Treatment of fluconazoleresistant candidiasis with voriconazole in patients with AIDS. AIDS 1998; 12: 2227-2228.
7. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol 1997; 97: 663-665.
8. van't Hek LG, Verweij PE, Weemaes CM, van Dalen R, Yntema JB, Meis JF. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Cure Med 1998; 157: 1694-1696.
9. Andriole VT, Miniter P, George D, Kordick D, Patterson TF. Animal models: Their usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. Clin Infect Dis 1992; 14 ((Suppl. 1)): S134-S138.
10. Stevens DA. Animal models in the evaluation of antifungal drugs. J Mycol Med 1996; 6: 7-10.
11. Patterson B, Coates P. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: disposition in man. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society of Microbiology, 1995: Abstract F78.
12. Jezquel S, Clark M, Cole S, Evans K, Wastall P. UK-109,496, a novel wide-spectrum triazole derivative for the treatment of fungal infections: preclinical pharmacokinetics. Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society of Microbiology, 1995: Abstract F76.
13. Martin MV, Yates J, Hitchcock CA. Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs. Antimicrob Agents Chemother 1997; 41: 13-16.
14. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40-79.
15. Chan WK, Nguyen LT, Miller VP, Harris RZ. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci 1998; 62: L135-142.
16. Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Safety 1998; 18: 251-272.
17. Sugar AM. Use of amphotericin B with azole antifungal drugs: What are we doing? Antimicrob Agents Chemother 1995; 39: 1907-1912.
18. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 1998; 11: 252-259.